Moreover, both ln/ob-aT bASCs stimulate the gene expression of ATM, an essential component of the DNA double-strand break repair mechanism, which may explain reduced DNA foci number and decreased apoptotic response in breast cancer cells treated with DTX, since the combination of ATM and ATR inhibitors is already used to re-sensitize breast cancer cells in clinical trials [94]. This evidence concerns the gene ATR and breast cancer.